Middelkoop, Mei AnDe Lange, Maria E.Clark, T. JustinMol, Ben Willem J.Bet, Pierre M.Huirne, Judith A.F.Hehenkamp, Wouter J.K.2023-03-312023-03-312022-05-01Middelkoop, M A, De Lange, M E, Clark, T J, Mol, B W J, Bet, P M, Huirne, J A F & Hehenkamp, W J K 2022, 'Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids', Human Reproduction, vol. 37, no. 5, pp. 884-894. https://doi.org/10.1093/humrep/deac0090268-1161https://hdl.handle.net/2164/2038611455837engclinical trialsleiomyomaPhase IIIrandomized controlled trialsrisk evaluation and mitigationulipristal acetateR MedicineReproductive MedicineObstetrics and GynaecologySupplementary DataRJournal item10.1093/humrep/deac009http://www.scopus.com/inward/record.url?scp=85129998224&partnerID=8YFLogxK375